Literature DB >> 24770775

Tobacco experimental model to induce urinary bladder neoplasms.

José Alexandre Colli Neto1, José Hélio Zen Júnior1, André Del Negro2, Nelson Adami Andreollo2, Marina Rachel Araujo3, Alfio José Tincani2.   

Abstract

OBJECTIVE: to develop an experimental model of exposure to tobacco burning (cigarette) products to assess the effects of its chronic use in relation to cancers of the bladder.
METHODS: the animals were chronically exposed to the burning tobacco products in a semi-open chamber to simulate smoking. Thirty young Wistar rats were divided into two groups: one with 20 animals simulating smoking for six months, and ten not exposed control animals for the same period. After exposure by inhalation of cigarette smoke, animals were euthanized and subjected to histopathological study of the bladder wall.
RESULTS: no tumor was found but mild and non significant alterations. The studies of hemo-oximetry (carboxyhemoglobin and methemoglobin) and the concentration of carbon dioxide (CO2) confirm that the animals were exposed to high concentrations of tobacco smoke and its derivatives.
CONCLUSION: no bladder mucosal neoplasia was found in the pathological study of animals. The developed experimental models were highly efficient, practical and easy to use and can be used in other similar studies to determine the harmful effects caused by smoking.

Entities:  

Mesh:

Year:  2014        PMID: 24770775     DOI: 10.1590/s0100-69912014000100011

Source DB:  PubMed          Journal:  Rev Col Bras Cir        ISSN: 0100-6991


  2 in total

1.  Cigarette smoke extract-induced proliferation of normal human urothelial cells via the MAPK/AP-1 pathway.

Authors:  Hao Geng; Li Zhao; Zhaofeng Liang; Zhiqiang Zhang; Dongdong Xie; Liangkuan Bi; Yi Wang; Tao Zhang; Lei Cheng; Dexin Yu; Caiyun Zhong
Journal:  Oncol Lett       Date:  2016-11-22       Impact factor: 2.967

2.  Time for Cigarette Smoke Exposure Chambers?

Authors:  Dieter J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2016-03-14       Impact factor: 3.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.